BIO-key International (BKYI) vs. Its Competitors Critical Comparison

BIO-key International (NASDAQ:BKYI) is one of 953 public companies in the “Software” industry, but how does it compare to its rivals? We will compare BIO-key International to similar businesses based on the strength of its institutional ownership, profitability, analyst recommendations, dividends, earnings, risk and valuation.

Insider and Institutional Ownership

26.5% of BIO-key International shares are owned by institutional investors. Comparatively, 41.8% of shares of all “Software” companies are owned by institutional investors. 4.0% of BIO-key International shares are owned by company insiders. Comparatively, 19.9% of shares of all “Software” companies are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Volatility and Risk

BIO-key International has a beta of 0.52, meaning that its stock price is 48% less volatile than the S&P 500. Comparatively, BIO-key International’s rivals have a beta of 1.34, meaning that their average stock price is 34% more volatile than the S&P 500.

Profitability

This table compares BIO-key International and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BIO-key International	-50.01%	-67.31%	-40.28%
BIO-key International Competitors	-612.69%	20.88%	-8.98%

Analyst Ratings

This is a summary of recent recommendations for BIO-key International and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BIO-key International	1	1	0	0	1.50
BIO-key International Competitors	5732	21470	44775	1493	2.57

As a group, “Software” companies have a potential upside of 25.91%. Given BIO-key International’s rivals stronger consensus rating and higher possible upside, analysts clearly believe BIO-key International has less favorable growth aspects than its rivals.

Valuation and Earnings

This table compares BIO-key International and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
BIO-key International	$6.70 million	-$7.16 million	-0.57
BIO-key International Competitors	$1.81 billion	$385.92 million	109.82

BIO-key International’s rivals have higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Summary

BIO-key International rivals beat BIO-key International on 12 of the 13 factors compared.

About BIO-key International

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.